Vladimir Kirejev

Vladimir Kirejev

Auto-generated profile, based on publicly available information

Vladimir Kirejev

Fluicell AB, Flöjelbergsgatan 8C, 431 37, Mölndal, Sweden

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
MMMilo Malanga
Milo Malanga
Mimimorena SeggioMimimorena Seggio
Mimimorena Seggio
VKVladimir Kirejev
Vladimir Kirejev
AFAurore Fraix
Aurore Fraix
IBIvana Di Bari
Ivana Di Bari
SSSalvatore Sortino
Salvatore Sortino
We report herein on a novel water-soluble β-cyclodextrin-branched polymer covalently integrating a fluorescein moiety and a nitric oxide (NO) photodonor within its macromolecular skeleton. Photoexcitation with visible light induces the parallel activation of the two chromophores, which results in the green fluorescence emission suitable for imaging accompanied by NO release for therapy. In fact, this polymer internalizes in squamous carcinoma cancer cells in vitro, visualized by fluorescence microscopy, and induces cell mortality as result of the NO photo-decaging. The non-covalent drug delivery capability of this new material is also demonstrated using a hydrophobic photosensitizer for photodynamic therapy as a probe.

10 November 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GJGavin D. M. Jeffries
Gavin D. M. Jeffries
SXShijun Xu
Shijun Xu
TLTatsiana Lobovkina
Tatsiana Lobovkina
VKVladimir Kirejev
Vladimir Kirejev
FTFlorian Tusseau
Florian Tusseau
OOOwe Orwar
Owe Orwar
Significant strides have been made in the development of in vitro systems for disease modelling. However, the requirement of microenvironment control has placed limitations on the generation of relevant models. Herein, we present a biological tissue printing approach that employs open-volume microfluidics to position individual cells in complex 2D and 3D patterns, as well as in single cell arrays. The variety of bioprinted cell types employed, including skin epithelial (HaCaT), skin cancer (A431), liver cancer (Hep G2), and fibroblast (3T3-J2) cells, all of which exhibited excellent viability and survivability, allowing printed structures to rapidly develop into confluent tissues. To demonstrate a simple 2D oncology model, A431 and HaCaT cells were printed and grown into tissues. Furthermore, a basic skin model was established to probe drug response. 3D tissue formation was demonstrated by co-printing Hep G2 and 3T3-J2 cells onto an established fibroblast layer, the functionality of which was probed by measuring albumin production, and was found to be higher in comparison to both 2D and monoculture approaches. Bioprinting of primary cells was tested using acutely isolated primary rat dorsal root ganglia neurons, which survived and established processes. The presented technique offers a novel open-volume microfluidics approach to bioprint cells for the generation of biological tissues.

17 April 2018 in Small
Verified
Journal Article
Closed access
PDF file
VKVladimir Kirejev
Vladimir Kirejev
BDBaharan Ali Doosti
Baharan Ali Doosti
MSMehrnaz Shaali
Mehrnaz Shaali
GJGavin D. M. Jeffries
Gavin D. M. Jeffries
TLTatsiana Lobovkina
Tatsiana Lobovkina